Bicocca Open Archive

Logo unimib boa
BALDUZZI, ADRIANA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.787
AS - Asia 12.274
EU - Europa 9.162
SA - Sud America 1.915
Continente sconosciuto - Info sul continente non disponibili 1.030
AF - Africa 308
OC - Oceania 49
Totale 45.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.726
SG - Singapore 3.950
IT - Italia 3.098
VN - Vietnam 2.408
CN - Cina 2.078
HK - Hong Kong 1.541
RU - Federazione Russa 1.533
BR - Brasile 1.403
DE - Germania 860
SE - Svezia 770
CA - Canada 758
IE - Irlanda 757
BD - Bangladesh 616
GB - Regno Unito 399
FR - Francia 390
IN - India 384
UA - Ucraina 315
FI - Finlandia 234
ID - Indonesia 193
AR - Argentina 178
KR - Corea 161
TR - Turchia 155
ES - Italia 140
JP - Giappone 133
MX - Messico 131
NL - Olanda 122
IQ - Iraq 111
PL - Polonia 101
ZA - Sudafrica 94
AT - Austria 86
EC - Ecuador 85
PH - Filippine 75
PK - Pakistan 73
CO - Colombia 63
VE - Venezuela 50
BE - Belgio 49
SA - Arabia Saudita 49
CH - Svizzera 46
CL - Cile 45
AU - Australia 40
UZ - Uzbekistan 39
LT - Lituania 38
CZ - Repubblica Ceca 37
GR - Grecia 37
IR - Iran 35
MA - Marocco 33
PY - Paraguay 33
EG - Egitto 31
IL - Israele 31
JM - Giamaica 30
AE - Emirati Arabi Uniti 28
DK - Danimarca 28
JO - Giordania 28
KE - Kenya 28
MY - Malesia 26
CR - Costa Rica 25
ET - Etiopia 25
TN - Tunisia 25
NP - Nepal 24
UY - Uruguay 23
PE - Perù 21
PT - Portogallo 21
TW - Taiwan 21
HN - Honduras 18
TH - Thailandia 17
TT - Trinidad e Tobago 17
KZ - Kazakistan 15
DO - Repubblica Dominicana 14
GT - Guatemala 14
PA - Panama 14
RO - Romania 14
BG - Bulgaria 13
DZ - Algeria 13
OM - Oman 13
AZ - Azerbaigian 12
NI - Nicaragua 12
AL - Albania 11
BO - Bolivia 11
NG - Nigeria 11
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
NZ - Nuova Zelanda 9
AO - Angola 7
BH - Bahrain 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
PS - Palestinian Territory 7
SV - El Salvador 7
EE - Estonia 6
NO - Norvegia 6
LV - Lettonia 5
LY - Libia 5
MU - Mauritius 5
PR - Porto Rico 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
EU - Europa 4
HR - Croazia 4
Totale 44.419
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Singapore 2.095
Ashburn 2.067
Hong Kong 1.506
San Jose 1.310
Fairfield 1.012
Milan 929
Woodbridge 811
Dublin 736
Ho Chi Minh City 735
Hanoi 606
Wilmington 601
Chandler 525
Houston 512
Toronto 497
New York 492
Santa Clara 480
Frankfurt am Main 466
Seattle 465
Dallas 442
Council Bluffs 427
Los Angeles 406
Chicago 380
Hefei 324
Cambridge 289
Dearborn 286
Beijing 278
Jacksonville 269
Rome 243
Princeton 235
The Dalles 198
Lauterbourg 168
Moscow 164
Phoenix 152
Seoul 148
São Paulo 147
Buffalo 144
Boardman 131
Jakarta 131
Shanghai 118
Helsinki 114
Lawrence 113
Nanjing 96
Altamura 92
Columbus 89
Atlanta 88
Munich 83
Da Nang 80
Orem 77
Denver 76
San Diego 75
Tokyo 74
Haiphong 71
Montreal 71
Figino 70
London 70
Rio de Janeiro 66
Nuremberg 65
Warsaw 65
Naples 62
Brooklyn 57
Turin 56
Baghdad 51
Salt Lake City 51
Biên Hòa 50
Andover 47
Ha Long 47
Chennai 46
Johannesburg 46
Guangzhou 45
Dhaka 42
Florence 42
Lissone 42
Lappeenranta 41
San Francisco 40
Kent 39
Quận Bình Thạnh 39
Turku 39
Fremont 38
Mexico City 38
Miami 38
Boston 37
Dong Ket 37
Tashkent 37
Washington 37
Lachine 36
New Delhi 36
Poplar 36
Vienna 35
Brussels 34
Hải Dương 34
Paris 34
Changsha 33
Genoa 33
Istanbul 33
Nanchang 33
Ankara 31
Brasília 31
Stockholm 31
Tianjin 31
Totale 26.281
Salva come PNG Salva come JPEG
Nome #
ABO incompatibile graft management in pediatric transplantation 753
Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations 598
Long-term complications after allogeneic hematopoietic stem cell transplantation for pediatric patients with acute leukemia or myelodysplastic syndrome given either a Treosulfan- or a Busulfan-based conditioning regimen: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study 512
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 510
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 492
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 489
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 489
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 489
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 463
Avascular necrosis of the talus in pediatric acute lymphoblastic leukemia: Current concepts 441
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 428
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 426
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 405
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: Practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group 404
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 403
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 386
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 373
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 363
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 362
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 354
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 353
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload 342
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 340
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 335
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 329
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 329
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 326
Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up 320
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 319
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015 319
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 318
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 316
Thyroid disorders following hematopoietic stem cell transplantation in childhood: the impact of the conditioning regimen on thyroid dysfunction, volume changes and occurrence of nodules 316
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 310
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche 309
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 303
Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life 302
Pubertal attainment and Leydig cell function following pediatric hematopoietic stem cell transplantation: a three-decade longitudinal assessment 301
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 301
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience 298
Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies 288
Late Adverse Events Following Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukaemia: State of the Art 285
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 285
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 283
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 282
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study 281
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 277
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia 270
PENTRAXIN 3 PLASMA LEVELS AT GRAFT-VERSUS-HOST DISEASE ONSET PREDICT DISEASE SEVERITY AND RESPONSE TO THERAPY IN CHILDREN GIVEN HEMATOPOIETIC STEM CELL TRANSPLANTATION 268
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 267
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 264
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 264
Pentraxin-3 Increases At The Onset Of Graft-Versus-Host Disease In Transplanted Patients 264
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis 264
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study 260
Moebius syndrome and hypopituitarism: a case of multiple pituitary hormone deficiency and revision of the literature 258
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 256
Isolated leukopenia in children and adolescents referred to a Pediatric Hematology Clinic 254
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial 253
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 252
Donor selection in Adults and Pediatrics 248
Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: A study from the infectious diseases working party of the european group for blood and marrow transplantation 248
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission 245
Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study 244
Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach 243
Transplant-related toxicity and mortality: An AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia 243
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia 242
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing 237
The impact of MRD in HCT for childhood ALL 236
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 236
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment 233
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 232
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome 231
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: The impact of the waiting time 230
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 225
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study 224
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (vhr) childhood acute lymphoblastic leukaemia in first complete remission 220
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 218
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission 218
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG 218
Successful sequential liver and hematopoietic stem cell transplantation in a patient with Fanconi anemia 217
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 217
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP) 216
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment 216
Sport therapy: Allenamento di precisione dalla diagnosi al termine del trattamento oncologico in bambini e adolescenti con emopatia maligna [Sport therapy: Precision exercise training from diagnosis to the end of treatment in children/adolescents with malignant hemopathies] 214
Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation 212
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions 212
Letermovir Primary and Secondary Prophylaxis in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplant 211
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 211
Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? 209
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes 209
A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization 208
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PDWP retrospective study 208
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) 208
Diagnostic Management of Pediatric Bronchiectasis: A Literature Review and Clinical Examples 208
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children 206
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL 204
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial 203
More precisely defining risk peri-HCT in pediatric ALL: Pre- vs post-MRD measures, serial positivity, and risk modeling 203
Tetralogy of Fallot with absent pulmonary valve: definitive diagnosis by two-dimensional echocardiography 202
Totale 29.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 0 159 78 113 74 86 129 122 130 241
2022/20232.682 318 716 163 186 225 418 53 195 217 25 92 74
2023/20242.385 77 69 133 123 300 544 458 88 238 54 77 224
2024/20256.752 345 882 361 307 455 259 311 244 674 862 752 1.300
2025/202619.042 2.332 1.384 1.289 2.015 1.790 833 2.270 774 1.805 1.719 1.157 1.674
2026/20275.121 1.031 1.318 2.288 484 0 0 0 0 0 0 0 0
Totale 45.525